Hutch News

Hutch News

Stories tagged 'Gary Lyman'

Big takeaways from ASCO

Immunotherapy, precision medicine and patient-powered research among the highlights of the world’s largest cancer conference

June 9, 2016 | By Diane Mapes / Fred Hutch News Service

The world's largest cancer conference just ended. Fred Hutch experts and others weigh in on some of the big takeaways.

View story >


Forgotten patients: New guidelines help those with head-and-neck cancers

Stigma, isolation and medical complexity may keep patients from getting all the care they need; recommendations aim to change that

April 8, 2016 | By Diane Mapes and Sabrina Richards / Fred Hutch News Service

Head-and-neck cancer survivors can have enormous aftereffects from the disease and its treatment. New survivorship guidelines just released by the American Cancer Society should help them get the support they need.

View story >


Collaborating to boost value-based care

HICOR hammers out solutions, addresses hard questions on cost and cancer care at third annual summit

April 6, 2016 | By Diane Mapes / Fred Hutch News Service

Patients, providers and health economists joined forces last Friday in Seattle to improve patient outcomes during HICOR's third annual Value in Cancer Care Summit. Read our coverage.

View story >


6 questions in cancer immunotherapy

From cancer vaccines to engineered T cells, experts weigh in on the big unknowns

March 18, 2016 | by Susan Keown / Fred Hutch News Service

Fred Hutch immunotherapy experts share their perspectives on a few of the big questions in cancer immunotherapy research — and the steps that they and their colleagues are taking to answer them as quickly as they can.

View story >


‘This is the future of oncology’

Fred Hutch researcher helps lay crucial groundwork for precision medicine, improved patient care

March 4, 2016 | By Diane Mapes / Fred Hutch News Service

A new report sets basic ground rules and goals for the rapidly emerging field of precision medicine, which is being used more and more in cancer treatment. Fred Hutch's Dr. Gary Lyman was in on it.

View story >


‘Close to criminal’

A Fred Hutch researcher speaks out on the human cost of the ‘unfettered, unbridled greed’ within our health care system

Feb. 11, 2016 | By Dr. Gary Lyman, as told to Diane Mapes

As an oncologist, I've had patients delay or actually stop treatment because of the high cost. They're stopping and they're dying as a result. That's why I've taken a stand with many of my colleagues around the country to call attention to these pricing issues and how unsustainable and devastating they are to our patients.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.